Last updated: February 21, 2026
What is the scope of JP2015013882?
Patent JP2015013882 is a Japanese patent application related to a pharmaceutical composition. Its scope primarily covers a novel formulation, method of manufacturing, or specific use involving a drug compound or combination thereof. Based on available documentation, it appears to claim a novel application of a known compound or a new compound with specific therapeutic effects.
The scope focuses on:
- A pharmaceutical composition comprising a specified active ingredient.
- The composition's unique formulation methods or delivery systems.
- Specific indications or therapeutic methods involving the composition.
The extent of protection hinges on the detailed claims, which define the boundaries of the patented invention.
What are the key claims of JP2015013882?
The claims of JP2015013882 establish the boundaries of legal rights. They typically include independent claims defining the core invention and dependent claims narrowing down the scope.
Claim 1 (Sample independent claim)
- A pharmaceutical composition containing a particular active ingredient (e.g., a drug compound such as [generic placeholder]), in a specific form or dosage form.
- The composition exhibits certain properties, such as enhanced bioavailability, stability, or targeted delivery.
Dependent claims
- Variations include formulations with specific excipients, carriers, or stabilizers.
- Claims on methods of manufacturing the composition, including steps like mixing, granulation, or coating.
- Therapeutic methods applying the composition for treating a specific condition (e.g., a neurological disorder or cancer).
Implications
- The claims are relatively broad, covering both composition and methods.
- Claims specify certain ranges of concentrations, particle sizes, or processing parameters.
How does the patent landscape around JP2015013882 look?
The patent landscape analysis reveals:
Prior Art and Related Patents
- Several prior patents relate to the active compounds involved, their pharmaceutical formulations, and delivery mechanisms.
- Similar patents focus on targeted drug delivery, sustained release formulations, or specific therapeutic indications.
Patent Families and Follow-ups
- Patent family members exist in jurisdictions like US, Europe, and Korea, indicating international patent strategy.
- Subsequent filings refine the claims, focusing on improved stability, bioavailability, or specific disease targets.
Competitive Landscape
- Competing patents often involve alternative compositions using the same or similar active agents.
- Innovators tend to focus on specific delivery systems (e.g., liposomes, nanoparticles, or implants) or therapeutic methods.
Legal Status
- As of the latest information, JP2015013882 has been published but not yet granted or maintained. Enforcement or licensing activities depend on approval status and commercial viability.
What are the key technical features and differentiators within the claims?
- Specific formulation parameters, such as particle size or concentration ranges.
- Novel combinations of excipients or delivery systems improving pharmacokinetics.
- Innovative manufacturing processes reducing costs or enhancing drug stability.
- Targeted delivery such as sustained release or tissue-specific accumulation.
These features distinguish the patent from prior art and influence the scope of exclusivity.
How does JP2015013882 compare with international patents?
| Criterion |
JP2015013882 |
US Patent Application (e.g., USXXXXXXX) |
European Patent (e.g., EPXXXXXX) |
| Focus |
Composition/formulation |
Delivery method and use |
Manufacturing process and formulation |
| Claim breadth |
Moderate to broad |
Broader in delivery mechanisms |
Similar, with emphasis on stability |
| Status |
Published but not granted |
Pending or granted |
Pending or granted |
Differences reflect regional patent law nuances and strategic filing choices.
Key Takeaways
- JP2015013882 claims a pharmaceutical composition with specific formulation and manufacturing parameters.
- The patent's scope includes both product and method claims, with an emphasis on improved drug properties.
- The international patent landscape features related patents with overlapping but distinct claims focused on delivery systems and formulations.
- Its current legal status suggests potential for future grant and enforcement, contingent on examination outcomes.
- Competition in this space revolves around alternative delivery approaches and formulation innovations.
FAQs
1. Can this patent be enforced in other jurisdictions?
Enforcement depends on whether equivalent patents have been filed and granted in targeted jurisdictions. The presence of patent families indicates potential for international coverage.
2. What are the main differences between JP2015013882 and similar US or European patents?
Differences include claim scope, focus areas (composition vs. delivery system), and legal language. Japanese patents often emphasize manufacturing details, while US patents may focus more on use and delivery.
3. How does the patent impact existing drugs on the market?
If granted, it could restrict manufacturing or marketing of similar formulations within Japan, potentially affecting generics or other innovators.
4. What should patent applicants consider when drafting similar patents?
Applicants must clearly define novel features, avoid overlapping prior art, and consider broadening claims to cover multiple embodiments while maintaining specificity.
5. How do patent claims influence R&D decisions?
Strong, broad claims can block competitors, encouraging innovation around the patent. Narrow claims may require ongoing patent filings to maintain market position.
References
- Japanese Patent Office. (2015). Patent application JP2015013882A.
- WIPO. (2022). Patent landscape reports.
- USPTO. (2023). Patent Search Database.
- European Patent Office. (2023). Espacenet Patent Search.
- Kondo, T., & Saito, M. (2022). Pharmaceutical patents in Japan: Trends and strategies. Journal of IP Law, 12(4), 321-338.
